Latest filing published 02 Apr 2021 for Teladoc Health, Inc., €1.5M.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 3 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -37.4%Entry US$16.78 · Close at T+365 US$10.50
- +265.2%Entry US$5.52 · Close at T+365 US$20.16
- +60.7%Entry US$11.78 · Close at T+365 US$18.93
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Glen Tullman: trading record in brief
Glen Tullman discloses dealings in 3 companies, chiefly Veradigm Inc., Livongo Health, Inc. and Teladoc Health, Inc. Over a trading history stretching from 17 January 2006 to 1 April 2021, the count stands at 130 filings.
On the open market, the record shows 3 purchases worth €618k and 39 sales worth €225.8M. The net balance comes to €225.2M on the selling side. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 28 share grants and 23 option exercises. 2021 to date brings no purchases and 10 sales.
A typical purchase (the median) is worth €140k. After 3 purchases with a full 90-day history, the hit rate stands at 67% and the median 90-day move at +11.7%. Past outcomes like these are no guarantee of what comes next.
The newest entry dates from 2 April 2021: an option exercise of €1.5M, in Teladoc Health, Inc. The last purchase on record was published on 23 August 2011, which is 5,556 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Glen Tullman
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 329,863 shares@ US$5.2640.7% of flowCommon StockSEC:0001179110-21-004092:0
- 60,148 shares@ US$182.78Common StockSEC:0001179110-21-004092:1
- 45,089 shares@ US$183.78Common StockSEC:0001179110-21-004092:2
- 44,825 shares@ US$184.68Common StockSEC:0001179110-21-004092:3
- 24,759 shares@ US$185.80Common StockSEC:0001179110-21-004092:4
- 38,977 shares@ US$186.92Common StockSEC:0001179110-21-004092:5
- 98,588 shares@ US$187.85Common StockSEC:0001179110-21-004092:6
- 17,477 shares@ US$188.45Common StockSEC:0001179110-21-004092:7
- 164,931 shares@ US$5.2619.8% of flowCommon StockSEC:0001179110-21-002719:0
- 164,931 shares@ US$226.06Common StockSEC:0001179110-21-002719:1
- 164,931 shares@ US$5.2619.8% of flowCommon StockSEC:0001179110-21-001277:0
- 164,931 shares@ US$262.61Common StockSEC:0001179110-21-001277:1
- 164,931 shares@ US$225.12Common StockSEC:0001179110-21-000672:1
- 164,931 shares@ US$5.2619.7% of flowCommon StockSEC:0001179110-21-000672:0
- 19,941 shares0Common StockSEC:0001639225-20-000060:0
- 12,080 shares0Common StockSEC:0001639225-20-000060:1
- 1,185,097 shares0Common StockSEC:0001639225-20-000060:2
- 109,748 shares0Common StockSEC:0001639225-20-000060:3
- 176,361 shares0Common StockSEC:0001639225-20-000060:4
- 195,277 shares0Common StockSEC:0001639225-20-000060:5
- 37,712 shares0Common StockSEC:0001639225-20-000060:6
- 940,788 shares0Common StockSEC:0001639225-20-000060:7
- 27,105 shares0Common StockSEC:0001639225-20-000060:8
- 173,041 shares0Common StockSEC:0001639225-20-000060:9
- 992,679 sharesCommon StockSEC:0001639225-20-000060:10
25 of 130 declarations
